Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Starboard's words were echoed by Gregg Gilbert, an analyst at Deutsche Bank.
In a research report on Tuesday, Gilbert stated that he upgraded Perrigo's stock on July 22 based on the premise that investors would re-focus on Perrigo as a "company with decent growth prospects and durable cash flows."
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
The analyst also suggested that after meeting with Perrigo's management team, the senior executives are now "more open-minded than ever" to consider strategic alternatives and the timing of Starboard's involvement could help create "multiple routes to value enhancement from the current price."
Gilbert also studied the math behind some of Starboard's suggestions, including the sale of Rx Pharma and/or Tysabri. Here is what the analyst wrote:
"For this analysis, we started with theoretical sale proceeds based on acquisition multiples for Rx Pharma (yields $5.4 billion) and our DCF model for Tysabri (yields $3.1 billion). We applied part of the proceeds to pay down debt in order to maintain a leverage ratio in 2017 similar to our estimate for the overall company, and the balance for share repurchases to offset EPS dilution.
"Our preliminary analysis for the separation of both segments yields EPS dilution of ~22 percent/16 percent/12 percent/10 percent in 2017/18/19/20. The EPS dilution could be more than offset by P/E multiple expansion as investors tend to pay significantly higher multiples for consumer-facing businesses with durable cashflow potential."
Shares of Perrigo remain Buy rated with an unchanged $105 price target.
Full ratings data available on Benzinga Pro.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.